Company: STAA
Filing Date: 2025-10-15
Form Type: DFAN14A
Source: 0001213900-25-099192
Chunk: 1

Company: STAAR SURGICAL CO
Filing Date: 2025-10-15
Form: DFAN14A
Chunk 1
---
 the “Special Meeting”). The Participants have filed a definitive proxy statement on Schedule 14A (the “Definitive
Proxy Statement”) and accompanying GREEN Proxy Card to be used in connection with any such solicitation of proxies
from the Company’s stockholders for the Special Meeting. STOCKHOLDERS OF THE COMPANY ARE URGED TO READ THESE MATERIALS (INCLUDING ANY AMENDMENTS OR SUPPLEMENTS THERETO) AND ANY OTHER RELEVANT DOCUMENTS THAT THE PARTICIPANTS HAVE FILED OR WILL FILE WITH THE U.S. SECURTIES AND EXCHANGE COMMISSION (THE “SEC”) BECAUSE THEY CONTAIN OR WILL CONTAIN IMPORTANT INFORMATION, INCLUDING ABOUT THE MATTERS TO BE VOTED ON AT THE SPECIAL MEETING AND additional information relating to the Participants and their direct or indirect interests, by security holdings or otherwise. The Definitive Proxy Statement and accompanying GREEN Proxy
Card have been furnished to some or all of the Company’s stockholders and will be, along with other relevant documents, available
at no charge on the SEC’s website at https://www.sec.gov/.

Information about the Participants and a description
of their direct or indirect interests, by security holdings or otherwise, is contained on an amendment to Schedule 13D filed by the Participants
with the SEC on September 26, 2025 and is available here.

Exhibit 1

<div align='center'>Broadwood Partners: All Three Leading Proxy Advisory Firms Recommend STAAR Surgical Shareholders Vote “ AGAINST” Sale to Alcon

ISS Joins Glass Lewis, Egan-Jones, and Long-Term Shareholders in Opposing Proposed Transaction

Concludes There Is No Compelling Reason for Shareholders to Support Proposed Sale of STAAR

Broadwood Cautions STAAR’s Board Against Making Further Significant Decisions Without Robust Shareholder Involvement and Alignment After Mounting Opposition to the Deal</div>

NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates
(“Broadwood” or “we”) today announced that Institutional Shareholder Services Inc. (“ISS”), a leading
independent proxy advisory firm, has recommended that the shareholders of STAAR Surgical Company (“STAAR” or the “Company”)
(NASDAQ: STAA) vote “AGAINST” the Company’s proposed acquisition by Alcon Inc. (“Alcon”) (NYSE:
ALC) (the “Proposed Merger”) on the GREEN Proxy Card.

ISS is the third proxy